What is the price of Pralsetinib available in China?

It is understood that the original drug Pralsetinib (Pralsetinib) has been launched in China, but it has not yet entered the scope of medical insurance. The price of each box of 100mg*120 tablets may be around 60,000 yuan, which is expensive. This drug may be sold in domestic hospitals or pharmacies. The ingredients of original drugs marketed in China are basically the same as those of foreign original drugs. Platinib is indicated for the treatment of adult patients with metastatic RET fusion-positive non-small cell lung cancer (NSCLC) as detected by an FDA-approved test and for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET fusion-positive thyroid cancer who require systemic therapy and are refractory to radioactive iodine therapy, if radioactive iodine is indicated.